Literature DB >> 6772166

Neurohypophysial-hormone-responsive cell line derived from a dimethylbenzanthracene-induced rat mammary tumour.

M E Monaco, W R Kidwell, M E Lippman.   

Abstract

WRK-1, a cloned cell line derived from a rat mammary tumour, responds to physiological concentrations of vasopressin and pharmacological concentrations of oxytocin with increased incorporation of [14C]acetate into lipids and increased protein accumulation. The presence of pharmacological concentrations of insulin, which itself is active on the WRK-1 cells, further enhances the effects of the neurohypophysial hormones. Unlike the action of vasopressin on other responsive tissues, the stimulation of acetate incorporation by WRK-1 cells is not observed until 24 h after the addition of the hormone. The lipids synthesized in response to the hormones are predominantly polar lipids, rather than the triclyclycerold characteristic of the differentiated mammary gland. [1-Deaminocysteine, 8-D-arginine] vasopressin, a vasopressin analogue that lacks pressor activity, has no effect on WRK-1 cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6772166      PMCID: PMC1161886          DOI: 10.1042/bj1880437

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Oxytocin receptors: triggers for parturition and lactation?

Authors:  M S Soloff; M Alexandrova; M J Fernstrom
Journal:  Science       Date:  1979-06-22       Impact factor: 47.728

2.  Opposing effects of estradiol and progesterone on oxytocin receptors in rabbit uterus.

Authors:  R Nissenson; G Fluoret; O Hechter
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

3.  Vasopressin stimulation of mouse 3T3 cell growth.

Authors:  E Rozengurt; A Legg; P Pettican
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

4.  Association between vasopressin and corticosteroids in the palliative treatment of advanced breast cancer.

Authors:  E Bernard-Weil; J P Pilleron
Journal:  Oncology       Date:  1973       Impact factor: 2.935

5.  Separation of oxytocin from the substances that interfere with its biological assay on the isolated rat mammary gland.

Authors:  J Brovetto; J Olhaberry; M N Gioia de Coch; H Coda; C Fielitz; H M Cabot; A Fraga; J A Coch
Journal:  J Endocrinol       Date:  1967-07       Impact factor: 4.286

6.  Effect of a synthetic analogue of vasopressin in animals and in patients with diabetes insipidus.

Authors:  I Vávra; A Machová; V Holecek; J H Cort; M Zaoral; F Sorm
Journal:  Lancet       Date:  1968-05-04       Impact factor: 79.321

7.  Response of the nonpregnant uterus to vasopressin as an index of ovarian function.

Authors:  E Metzker Coutinho; A C Vieira Lopes
Journal:  Am J Obstet Gynecol       Date:  1968-10-15       Impact factor: 8.661

Review 8.  Metabolism of antidiuretic hormones.

Authors:  H D Lauson
Journal:  Am J Med       Date:  1967-05       Impact factor: 4.965

9.  Vasopressin-sensitive kidney adenylate cyclase. Differential effects of monovalent ions on stimulation by fluoride, vasopressin and guanylyl 5'-imidodiphosphate.

Authors:  C Roy; N C Le Bars; S Jard
Journal:  Eur J Biochem       Date:  1977-09

Review 10.  Ultrastructure of the human breast and its disorders.

Authors:  E R Fisher
Journal:  Am J Clin Pathol       Date:  1976-08       Impact factor: 2.493

View more
  6 in total

1.  Characterization of specific V1a vasopressin-binding sites on a rat mammary-tumour-cell line.

Authors:  G Guillon; C J Kirk; M N Balestre
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

2.  Purification of total RNA from human stool samples.

Authors:  R J Alexander; R F Raicht
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

3.  Vasopressin gene related products are markers of human breast cancer.

Authors:  W G North; S Pai; A Friedmann; X Yu; M Fay; V Memoli
Journal:  Breast Cancer Res Treat       Date:  1995-06       Impact factor: 4.872

4.  Evidence that mammalian phosphatidylinositol transfer protein regulates phosphatidylcholine metabolism.

Authors:  M E Monaco; R J Alexander; G T Snoek; N H Moldover; K W Wirtz; P D Walden
Journal:  Biochem J       Date:  1998-10-01       Impact factor: 3.857

5.  Stimulation, by vasopressin and other agonists, of inositol-lipid breakdown and inositol phosphate accumulation in WRK 1 cells.

Authors:  C J Kirk; G Guillon; M N Balestre; S Jard
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

6.  Immunohistochemical evaluation of vasopressin expression in breast fibrocystic disease and ductal carcinoma in situ (DCIS).

Authors:  William G North; Wendy Wells; Michael J Fay; Rennie S Mathew; Edward M Donnelly; Vincent A Memoli
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.